Date | Time | Source | Headline | Symbol | Company |
05/09/2012 | 5:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
05/09/2012 | 5:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
05/09/2012 | 5:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
05/09/2012 | 5:01PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
05/09/2012 | 4:59PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
05/09/2012 | 4:57PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
05/09/2012 | 4:57PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
05/04/2012 | 8:59AM | Business Wire | Forest Laboratories, Inc. to Present Cariprazine & Levomilnacipran Results from Phase 3 Trials at American Psychiatric Associ... | NYSE:FRX | Forest Road Acquisition Corp |
05/02/2012 | 2:29PM | Zacks | Earnings Scorecard: Forest Labs - Analyst Blog | NYSE:FRX | Forest Road Acquisition Corp |
04/27/2012 | 4:30AM | Zacks | Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics - Press Releases | NYSE:FRX | Forest Road Acquisition Corp |
04/26/2012 | 9:50AM | Zacks | Mylan Beats, Reaffirms Outlook - Analyst Blog | NYSE:FRX | Forest Road Acquisition Corp |
04/26/2012 | 3:00AM | Business Wire | Forest Laboratories, Inc. & Pierre Fabre Medicament Announce Third Positive Phase III Study for Levomilnacipran in Patients w... | NYSE:FRX | Forest Road Acquisition Corp |
04/24/2012 | 12:25PM | Zacks | Yet Another Delay for Forest Labs - Analyst Blog | NYSE:FRX | Forest Road Acquisition Corp |
04/23/2012 | 2:30AM | Business Wire | Ironwood and Forest Announce FDA Has Extended the Review Period for Linaclotide to September 2012 | NYSE:FRX | Forest Road Acquisition Corp |
04/19/2012 | 4:53PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
04/18/2012 | 2:55PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
04/17/2012 | 5:14PM | Business Wire | Forest Laboratories, Inc. to Host Investor Meeting to Review Company’s Late-Stage Product Development Pipeline & Commercial... | NYSE:FRX | Forest Road Acquisition Corp |
04/17/2012 | 4:09PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
04/17/2012 | 11:47AM | Zacks | Forest Hit by Lexapro Generics - Analyst Blog | NYSE:FRX | Forest Road Acquisition Corp |
04/17/2012 | 8:55AM | Dow Jones News | Forest Labs 4Q Net Falls 40% As Lexapro Patent Expires; Has Upbeat Year View | NYSE:FRX | Forest Road Acquisition Corp |
04/17/2012 | 8:00AM | Business Wire | Forest Laboratories, Inc. Reports Fiscal Year Fourth Quarter 2012 Earnings Per Share of $0.72 Including $0.06 Per Share of Ac... | NYSE:FRX | Forest Road Acquisition Corp |
04/09/2012 | 1:41PM | Zacks | Forest Buys Bystolic Rights - Analyst Blog | NYSE:FRX | Forest Road Acquisition Corp |
04/05/2012 | 12:50PM | Zacks | Teva Active on the Generics Front - Analyst Blog | NYSE:FRX | Forest Road Acquisition Corp |
04/04/2012 | 4:45PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
04/02/2012 | 4:15PM | Business Wire | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2012 Fourth Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
04/02/2012 | 3:24PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NYSE:FRX | Forest Road Acquisition Corp |
04/02/2012 | 9:10AM | Dow Jones News | Forest Laboratories Buys Blood Pressure Drug Bystolic From Janssen For $357 Million | NYSE:FRX | Forest Road Acquisition Corp |
04/02/2012 | 8:00AM | Business Wire | Forest Laboratories, Inc. Announces Buyout of Bystolic Royalties from Janssen Pharmaceutica NV | NYSE:FRX | Forest Road Acquisition Corp |
03/30/2012 | 12:33PM | Zacks | Delay in Forest Drug FDA Action Date - Analyst Blog | NYSE:FRX | Forest Road Acquisition Corp |
03/29/2012 | 2:30AM | Business Wire | Forest Laboratories and Almirall Announce FDA has Extended the Review Period for Aclidinium Bromide | NYSE:FRX | Forest Road Acquisition Corp |